These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 11772424)

  • 1. Peroxisome proliferator-activated receptors.
    Ziouzenkova O; Perrey S; Marx N; Bacqueville D; Plutzky J
    Curr Atheroscler Rep; 2002 Jan; 4(1):59-64. PubMed ID: 11772424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peroxisome proliferator-activated receptors in vascular biology and atherosclerosis: emerging insights for evolving paradigms.
    Plutzky J
    Curr Atheroscler Rep; 2000 Jul; 2(4):327-35. PubMed ID: 11122762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of the peroxisome proliferator-activated receptors (PPAR) in atherosclerosis.
    Neve BP; Fruchart JC; Staels B
    Biochem Pharmacol; 2000 Oct; 60(8):1245-50. PubMed ID: 11007963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peroxisome proliferator-activated receptor alpha in metabolic disease, inflammation, atherosclerosis and aging.
    Pineda Torra I; Gervois P; Staels B
    Curr Opin Lipidol; 1999 Apr; 10(2):151-9. PubMed ID: 10327283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The potential role of peroxisome proliferator-activated receptors on inflammation in type 2 diabetes mellitus and atherosclerosis.
    Plutzky J
    Am J Cardiol; 2003 Aug; 92(4A):34J-41J. PubMed ID: 12957325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Peroxisome proliferator-activated receptors (PPAR) in pathophysiology of the circulatory system and prospective use of agonists of these receptors in therapy].
    Bełtowski J; Wójcicka G; Jamroz A
    Postepy Hig Med Dosw; 2003; 57(2):199-217. PubMed ID: 12866356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peroxisome proliferator-activated receptors: are they involved in atherosclerosis progression?
    Puddu P; Puddu GM; Muscari A
    Int J Cardiol; 2003 Aug; 90(2-3):133-40. PubMed ID: 12957742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peroxisome proliferator-activated receptors in endothelial cell biology.
    Plutzky J
    Curr Opin Lipidol; 2001 Oct; 12(5):511-8. PubMed ID: 11561170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peroxisome proliferator-activated receptors: new targets for the pharmacological modulation of macrophage gene expression and function.
    Chinetti G; Fruchart JC; Staels B
    Curr Opin Lipidol; 2003 Oct; 14(5):459-68. PubMed ID: 14501584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic and additional vascular effects of thiazolidinediones.
    Martens FM; Visseren FL; Lemay J; de Koning EJ; Rabelink TJ
    Drugs; 2002; 62(10):1463-80. PubMed ID: 12093315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peroxisome proliferator-activated receptor-alpha activators regulate genes governing lipoprotein metabolism, vascular inflammation and atherosclerosis.
    Fruchart JC; Duriez P; Staels B
    Curr Opin Lipidol; 1999 Jun; 10(3):245-57. PubMed ID: 10431661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peroxisome proliferator-activated receptors (PPARs): nuclear receptors with functions in the vascular wall.
    Chinetti G; Fruchart JC; Staels B
    Z Kardiol; 2001; 90 Suppl 3():125-32. PubMed ID: 11374025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peroxisome proliferator-activated receptors and atherogenesis: regulators of gene expression in vascular cells.
    Marx N; Duez H; Fruchart JC; Staels B
    Circ Res; 2004 May; 94(9):1168-78. PubMed ID: 15142970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peroxisome proliferator-activated receptor (PPAR)-alpha: a pharmacological target with a promising future.
    van Raalte DH; Li M; Pritchard PH; Wasan KM
    Pharm Res; 2004 Sep; 21(9):1531-8. PubMed ID: 15497675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Orphan nuclear receptors find a home in the arterial wall.
    Laffitte BA; Tontonoz P
    Curr Atheroscler Rep; 2002 May; 4(3):213-21. PubMed ID: 11931719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peroxisome proliferator-activated receptors in atherosclerosis and inflammation--an update.
    Elangbam CS; Tyler RD; Lightfoot RM
    Toxicol Pathol; 2001; 29(2):224-31. PubMed ID: 11421489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correction of dysfunctional fatty acid metabolism using peroxisome proliferator activated receptor gamma agonists.
    Oakes ND; Ljung B; Camejo G
    J R Soc Med; 2002; 95 Suppl 42(Suppl 42):33-8. PubMed ID: 12216325
    [No Abstract]   [Full Text] [Related]  

  • 18. The role of PPARs in atherosclerosis.
    Duval C; Chinetti G; Trottein F; Fruchart JC; Staels B
    Trends Mol Med; 2002 Sep; 8(9):422-30. PubMed ID: 12223313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipolytic PPAR activation: new insights into the intersection of triglycerides and inflammation?
    Ziouzenkova O; Plutzky J
    Curr Opin Clin Nutr Metab Care; 2004 Jul; 7(4):369-75. PubMed ID: 15192437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Peroxisome proliferator activated nuclear receptors: possible role in the development of atherosclerosis].
    Evdokimova MA; Zateĭshchikov DA; Sidorenko BA
    Kardiologiia; 2003; 43(11):41-8. PubMed ID: 14671562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.